These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 24439219)
1. Cribriform and fused glands are patterns of high-grade pulmonary adenocarcinoma. Moreira AL; Joubert P; Downey RJ; Rekhtman N Hum Pathol; 2014 Feb; 45(2):213-20. PubMed ID: 24439219 [TBL] [Abstract][Full Text] [Related]
2. The new histologic classification of lung primary adenocarcinoma subtypes is a reliable prognostic marker and identifies tumors with different mutation status: the experience of a French cohort. Mansuet-Lupo A; Bobbio A; Blons H; Becht E; Ouakrim H; Didelot A; Charpentier MC; Bain S; Marmey B; Bonjour P; Biton J; Cremer I; Dieu-Nosjean MC; Sautès-Fridman C; Régnard JF; Laurent-Puig P; Alifano M; Damotte D Chest; 2014 Sep; 146(3):633-643. PubMed ID: 24676429 [TBL] [Abstract][Full Text] [Related]
3. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438 [TBL] [Abstract][Full Text] [Related]
4. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients. Russell PA; Barnett SA; Walkiewicz M; Wainer Z; Conron M; Wright GM; Gooi J; Knight S; Wynne R; Liew D; John T J Thorac Oncol; 2013 Apr; 8(4):461-8. PubMed ID: 23486266 [TBL] [Abstract][Full Text] [Related]
5. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification]. Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of complex glandular patterns in invasive pulmonary adenocarcinomas. Bossé Y; Gagné A; Althakfi W; Orain M; Fiset PO; Desmeules P; Joubert P Hum Pathol; 2022 Oct; 128():56-68. PubMed ID: 35872155 [TBL] [Abstract][Full Text] [Related]
7. Mitosis trumps T stage and proposed international association for the study of lung cancer/american thoracic society/european respiratory society classification for prognostic value in resected stage 1 lung adenocarcinoma. Duhig EE; Dettrick A; Godbolt DB; Pauli J; van Zwieten A; Hansen AR; Yang IA; Fong KM; Clarke BE; Bowman RV J Thorac Oncol; 2015 Apr; 10(4):673-81. PubMed ID: 25514800 [TBL] [Abstract][Full Text] [Related]
8. The clinical relevance of pathologic subtypes in metastatic lung adenocarcinoma. Clay TD; Do H; Sundararajan V; Moore MM; Conron M; Wright GM; McLachlan SA; Dobrovic A; Russell PA J Thorac Oncol; 2014 May; 9(5):654-63. PubMed ID: 24722155 [TBL] [Abstract][Full Text] [Related]
9. The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype. Kadota K; Yeh YC; Sima CS; Rusch VW; Moreira AL; Adusumilli PS; Travis WD Mod Pathol; 2014 May; 27(5):690-700. PubMed ID: 24186133 [TBL] [Abstract][Full Text] [Related]
10. Modified histologic classification as a prognostic factor in pulmonary adenocarcinoma. Hwang I; Park KU; Kwon KY Int J Surg Pathol; 2014 May; 22(3):212-20. PubMed ID: 24599899 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implication of EGFR gene mutations and histological classification in patients with resected stage I lung adenocarcinoma. Lin CY; Wu YM; Hsieh MH; Wang CW; Wu CY; Chen YJ; Fang YF PLoS One; 2017; 12(10):e0186567. PubMed ID: 29065153 [TBL] [Abstract][Full Text] [Related]
12. Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma. Warth A; Muley T; Kossakowski C; Stenzinger A; Schirmacher P; Dienemann H; Weichert W J Thorac Oncol; 2015 Apr; 10(4):638-44. PubMed ID: 25634008 [TBL] [Abstract][Full Text] [Related]
13. Histopathologic characteristics of lung adenocarcinomas with epidermal growth factor receptor mutations in the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification. Shim HS; Lee DH; Park EJ; Kim SH Arch Pathol Lab Med; 2011 Oct; 135(10):1329-34. PubMed ID: 21970488 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification in stage IB lung adenocarcinoma. Xu CH; Wang W; Wei Y; Hu HD; Zou J; Yan J; Yu LK; Yang RS; Wang Y Eur J Surg Oncol; 2015 Oct; 41(10):1430-6. PubMed ID: 26123994 [TBL] [Abstract][Full Text] [Related]
15. Interobserver reproducibility study of the histological patterns of primary lung adenocarcinoma with emphasis on a more complex glandular pattern distinct from the typical acinar pattern. Wang C; Durra HY; Huang Y; Manucha V Int J Surg Pathol; 2014 Apr; 22(2):149-55. PubMed ID: 24477939 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China. Song Z; Zhu H; Guo Z; Wu W; Sun W; Zhang Y Eur J Surg Oncol; 2013 Nov; 39(11):1262-8. PubMed ID: 24063970 [TBL] [Abstract][Full Text] [Related]
17. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. Russell PA; Wainer Z; Wright GM; Daniels M; Conron M; Williams RA J Thorac Oncol; 2011 Sep; 6(9):1496-504. PubMed ID: 21642859 [TBL] [Abstract][Full Text] [Related]
18. Cribriform adenocarcinoma of the lung: clinicopathologic, immunohistochemical, and molecular analysis of 15 cases of a distinctive morphologic subtype of lung adenocarcinoma. Mackinnon AC; Luevano A; de Araujo LC; Rao N; Le M; Suster S Mod Pathol; 2014 Aug; 27(8):1063-72. PubMed ID: 24390215 [TBL] [Abstract][Full Text] [Related]
19. Histologic features associated with metastatic potential in invasive adenocarcinomas of the lung. Xu L; Tavora F; Burke A Am J Surg Pathol; 2013 Jul; 37(7):1100-8. PubMed ID: 23681071 [TBL] [Abstract][Full Text] [Related]
20. Identification of transcriptional subgroups in EGFR-mutated and EGFR/KRAS wild-type lung adenocarcinoma reveals gene signatures associated with patient outcome. Planck M; Isaksson S; Veerla S; Staaf J Clin Cancer Res; 2013 Sep; 19(18):5116-26. PubMed ID: 23938291 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]